The recent week saw a slight slowdown in large startup funding announcements in the U.S., primarily due to the Fourth of July holiday. However, one notable exception was xAI, which secured an impressive $10 billion in debt and equity funding. This funding round highlights the ongoing interest in generative AI and reflects the growing trend of significant investments in technology startups across various sectors, including wealth management, procurement, and biotech.
xAI Secures $10 Billion
xAI, the generative AI startup founded by Elon Musk, has reportedly raised $10 billion in a combination of debt and equity financing. This funding includes $5 billion from strategic equity investments, with the remaining capital sourced through term loans and secured notes. This substantial raise underscores the increasing demand for AI-driven solutions and the potential for innovation in this space.
Key takeaways
- xAI raised roughly $10 billion in combined debt and equity, dominating an otherwise quiet Fourth of July week.
- The structure was about $5 billion in strategic equity with the balance raised through term loans and secured notes, rather than equity alone.
- Savvy Wealth raised a $72 million Series B led by Industry Ventures for AI tools aimed at financial advisers, taking its total to $106 million.
- Terrana Biosciences launched with $50 million from Flagship Pioneering to build RNA-based agricultural products that alter crop traits without changing the plant genome.
- The largest international round was Tel Aviv-based Cato Networks at $359 million Series G, valuing the security company above $4.8 billion.
Savvy Wealth Raises $72 Million
New York-based Savvy Wealth, which offers AI-enabled tools for financial advisers, announced a $72 million Series B funding round led by Industry Ventures. Founded in 2021, Savvy Wealth has now raised a total of $106 million, reflecting strong investor confidence in its technology and market potential.
Levelpath Closes $55 Million
Levelpath, a provider of AI-driven procurement tools, has raised over $55 million in a Series B round led by Battery Ventures. The San Francisco-based company’s platform utilizes AI agents to automate procurement tasks, aiming to streamline processes for businesses and enhance efficiency.
Terrana Biosciences Launches with $50 Million
Terrana Biosciences, based in Cambridge, Massachusetts, has launched with $50 million in initial funding from Flagship Pioneering. The company focuses on developing RNA-based agricultural products designed to enhance crop traits without altering the plant genome, showcasing innovation in agtech.
Campfire and Field Medical Each Raise $35 Million
Both Campfire, which provides enterprise resource planning tools, and Field Medical, a developer of cardiac ablation technology, secured $35 million in funding. Campfire’s Series A round was led by Accel, while Field Medical’s Series B financing was led by BioStar Capital and Cue Growth Partners, bringing their total funding to $89 million.
Syntis Bio Secures $33 Million
Syntis Bio, based in Boston, has raised $33 million in a Series A round led by Cerberus Ventures. The company specializes in developing oral therapies for obesity, diabetes, and rare diseases, and has also received up to $5 million in grants from the National Institutes of Health.
Ambrook and Emerald AI Raise $26 Million and $24.5 Million
Ambrook, which provides accounting software for farmers and ranchers, announced a $26.1 million Series A funding round led by Thrive Capital. Meanwhile, Emerald AI, based in Washington, D.C., raised $24.5 million in seed funding to develop software that helps the electric power system manage the increasing energy demands of AI.
Gallant Therapeutics Closes $18 Million
Gallant Therapeutics, a San Diego-based biotech startup focused on stem cell therapies for pets, has closed an $18 million Series B financing round led by Digitalis Ventures. This funding will support the company’s efforts to bring ready-to-use stem cell therapies to market.
International Funding Highlights
Despite a quieter week in the U.S., significant funding rounds were reported overseas. Notably, Tel Aviv-based Cato Networks raised $359 million in Series G funding, achieving a valuation of over $4.8 billion. Additionally, Mexico City-based Klar secured $190 million, including a $170 million Series C round led by General Atlantic.
Funding Methodology
This report tracks the largest announced funding rounds for U.S.-based companies from June 28 to July 3. While most rounds are represented, there may be slight delays in reporting as some announcements come in later in the week.
Frequently asked questions
Why would an AI company raise debt rather than pure equity?
Debt avoids diluting existing shareholders, which matters when a company's valuation is already high. For capital-intensive AI work — chips, data centres, power — term loans and secured notes can fund buildout without giving away more of the company.
What is Emerald AI working on?
Emerald AI raised $24.5 million in seed funding for software that helps the electric power system cope with rising demand from AI workloads, positioning it at the intersection of grid management and data centre growth.
How does Terrana's approach differ from conventional GMOs?
Terrana uses RNA-based products to enhance crop traits without editing the plant's genome. That distinction matters commercially, because genome modification carries a heavier regulatory and public-acceptance burden.
